Roles of Dopamine 2 Receptor Isoforms and G Proteins in Ethanol Regulated Prolactin Synthesis and Lactotropic Cell Proliferation

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Sengupta, Amitabha ^a   Sarkar, Dipak K ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CELL PROTEIN; DOPAMINE 2 RECEPTOR; DOPAMINE 25; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; PERTUSSIS TOXIN; PROLACTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; DEFENSE MECHANISM; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PROLACTIN SYNTHESIS; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; ETHANOL; FEMALE; GENE KNOCKDOWN TECHNIQUES; LACTOTROPHS; PROLACTIN; PROTEIN ISOFORMS; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84866500449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045593     Document Type: Article

References (42)

1. Sanchis R, Esquifino A, Guerri C, (1985) Chronic ethanol intake modifies estrous cyclicity and alters prolactin and LH levels. Pharmacol Biochem Behav 23: 221-224.
2. Mello NK, Mendelson JH, Teoh SK (1993) An overview of the effects of alcohol on neuroendocrine function in women, in National Institute on Alcohol Abuse and Alcoholism, Alcohol and the Endocrine System: Research Monograph 23, No. 93-3533, 139-170. National Institutes of Health, Washington DC.
3. Mendelson JH, Mello NK, (1988) Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther 245: 407-412.
4. Marchesi C, De Risio C, Campanini G, Majgini C, Piazza P, et al. (1992) TRH test in alcoholics: relationship of the endocrine results with neuroendocrinological and neuropsychological findings. Alcohol Alcohol 27: 531-537.
5. Seki M, Yoshida K, Okamura Y, (1991) A study on hyperprolactinemia in female patients with alcoholics. Jpn J Alcohol Drug Depend 26: 49-59.
6. Teoh SK, Lex BW, Mendelson JH, Mello NK, Cochin J, (1992) Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J Stud Alcohol 53: 176-182.
7. Välimäki M, Pelkonen R, Harkonen M, Tuomala P, Koistinen P, et al. (1990) Pituitary-gonadal hormones and adrenal androgens in non-cirrhotic female alcoholics after cessation of alcohol intake. Eur J Clin Invest 20: 177-181.
8. De A, Boyadjieva N, Pastorcic M, Sarkar DK, (1995) Potentiation of estrogen's mitogenic effect on the pituitary gland by alcohol consumption. Int J Oncol 7: 643-648.
9. De A, Boyadjieva N, Oomizu S, Sarkar DK, (2002) Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats. Alcohol Clin Exp Res 26: 1420-1429.
10. Freeman ME, Kanyicska B, Lerant A, Nagy G, (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80: 1523-631.
11. Ben-Jonathan N, Hnasko R, (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22: 724-763.
12. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG, (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
13. Robbins TW, Everitt BJ, (1999) Drug addiction: bad habits add up. Nature 398: 567-570.
14. Tupala E, Hall H, Bergstrom K, Sarkioja T, Rasanen P, et al. (2001) Dopamine D-2/D-3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol Psychiatry 6: 261-267.
15. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, et al. (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20: 1594-1598.
16. Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, et al. (1991) Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 8: 409-416.
17. Hietala J, West C, Syvalahti E, Nagren K, Lehikoinen P, et al. (1994) Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 116: 285-290.
18. Enjalbert A, Bockaert J, (1983) Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 23: 576-584.
19. Martinez de la Escalera G, Guthrie J, Weiner RI, (1988) Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway. Neuroendocrinology 47: 38-45.
20. Laccarino C, Samad TK, Mathis C, Kercret H, Picetti R, et al. (2002) Control of lactotroph proliferation by dopamine: essential role of signalling through D2 receptors ERKs. Proc Soc Nat Acad Sci (USA) 99: 14530-14535.
21. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, et al. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19: 103-113.
22. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, et al. (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19: 127-138.
23. Saiardi A, Bozzi Y, Baik JH, Borrelli E, (1997) Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19: 115-126.
24. Oomizu S, Boyadjieva N, Sarkar DK, (2003) Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor mRNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcohol Clin Exp Res 27: 975-980.
25. Hentges S, Boyadjieva N, Sarkar DK, (2000) Transforming growth factor-b3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141: 859-867.
26. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK, (1995) Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res 55: 4892-4898.
27. Caporali S, Imai M, Altucci L, Cancemi M, Caristi S, et al. (2003) Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Molecular Biology Cell 14: 5051-5059.
28. Chun T-Y, Gregg D, Sarkar DK, Gorski J, (1998) Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. Proceed Nat Acad Sci (USA) 95: 2325-2330.
29. Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva N, Chen CP, (2005) Dopamine and TGF-β1 interact to inhibit the growth of pituitary lactotropes. Endocrinology 146: 4179-4188.
30. Sengupta A, Deep P, Sarkar DK, (2012) Estrogen inhibits dopamine D2 receptor regulated Gi3 and Gs protein interactions to control prolactin production and cell proliferation in pituitary lactotropes. J Endocr 214: 67-78.
31. Chaturvedi K, Sarkar DK, (2008) Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment. Alcohol Clin Exp Res 32: 806-813.
32. Maurer RA, (1989) Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene. J Biol Chem 264: 6870-6873.
33. Ghahremani MH, Cheng P, Lembo PMC, Albert PR, (1999) Distinct roles for Gai2, Gai3, and Gbg in modulation of forskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 274: 9238-9245.
34. Civelli O, Bunzow JR, Grandy DK, (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33: 281-307.
35. Baertschi AJ, Audigier Y, Lledo PM, Israel JM, Bockaert J, et al. (1992) Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Mol Endocrinol 6: 2257-2265.
36. Wiens BL, Nelson CS, Neve KA, (1998) Contribution of serine residues to constitutive and agonist-induced signalling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations. Mol Pharmacol 54: 435-444.
37. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, et al. (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8: 4025-4034.
38. Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, et al. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342: 923-926.
39. Montmayeur JP, Bausero P, Amlaiky N, Maroteaux L, Hen R, et al. (1991) Differential expression of the mouse D2 dopamine receptor isoforms. FEBS Lett. 278: 239-243.
40. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, et al. (1994) Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neuroendocrinology 60: 314-322.
41. Guivarc'h D, Vincent JD, Vernier P, (1998) Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139: 4213-21.
42. Xu R, Parlow AF, Wang Y (2002) The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor. Brain Research 939 95-99.